Table 2 Characteristics of the patients in early clinical course (ECC) of UC and CD (within 3 years of diagnosis)

Gender

Male

49

43

Female

45

36

Age at diagnosis in years [median and IQR]*

42.7 (29.3–55.9)

34.2 (22.4 – 51.3)

Duration of diagnosis in months [median and IQR]*

21 (14–27)

21 (14–28)

Duration of follow up in months [median and IQR]*

18 (5–31)

9 (2–27)

Disease behavior [number (%)]

Admission with severe episode

20 (21.3)

9 (11.4)

Extensive (E2) or Pancolitis (E3)

26 (27.7)

–

Stricturing (B2) or penetrating (B3) disease

–

9 (11.4)

Perianal disease (P)

16 (20.5)

Treatment refractoriness [number (%)]

Steroid dependent

1 (1.1)

0

Steroid refractory

0

1 (1.3)

Frequently relapsing

9 (9.6)

6 (7.6)

Highest therapy

Immunomodulators

27 (29.0)

48 (61.5)

Anti-TNF agents

3 (3.2)

6 (7.7)

Disease complications

Stricture

3 (3.9)

Perforation

1 (1.3)

Bleeding

2 (2.1)

0

Surgery

2 (2.1)

7 (8.9)

Malignancy

1 (1.1)

1 (1.3)